The development and appraisal of a tool designed to find patients harmed by falsely labelled, falsified (counterfeit) medicines
Falsely labelled, falsified (counterfeit) medicines (FFCm’s) are produced or distributed illegally and can harm patients. Although the occurrence of FFCm’s is increasing in Europe, harm is rarely reported. The...
BMC Health Services Research 2017 17:419
Published on: 20 June 2017